If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
N-Nitroso Torsemide
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

N-Nitroso Torsemide

● Failure Report (NAP Test) Available

Catalogue No.:VE009746
CAS No.:N/A
Mol. Formula:C16H19N5O4S
Mol. Weight:377.4 g/mol

Additional information on N-Nitroso Torsemide

FDA Potency Category 5 NDSRI

1500 ng/day is the U.S. FDA’s current Acceptable Intake (AI) limit for N-nitroso-torsemide (NDSRI). Refer to the FDA nitrosamine page for the latest guidance.

Parent drug

Torasemide

IUPAC Name

N-(Isopropylcarbamoyl)-4-(nitroso(m-tolyl)amino)pyridine-3-sulfonamide

Pharmacopoeial Synonyms

N/A

Other Synonyms

Torasemide Nitroso Impurity 1

Smiles

O=S(C1=C(N(N=O)C2=CC=CC(C)=C2)C=CN=C1)(NC(NC(C)C)=O)=O

InChI

InChI=1S/C16H19N5O4S/c1-11(2)18-16(22)19-26(24,25)15-10-17-8-7-14(15)21(20-23)13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H2,18,19,22)

Description

N-Nitroso Torsemide is an N-nitroso derivative of the secondary amine present in Torasemide, which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds, including those set by USP, EMA, JP, and BP. This nitroso standard is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Torasemide production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits, quantify impurity levels, and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

N-Nitroso Torsemide: Synthesis Attempts and Failure Report (NAP Test)

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form